Aller au contenu principal
Accès ouvert déclaré 2018 article

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

59Citations signalées, ce qui n’est pas une note de qualité
179Institutions déclarées
21Pays d’affiliation déclarés

Rattachement africain : us, gb, au, se, fi, fr, dk, no, ca, es, pl, de, pt, be, my, bg, nl, jp, cn, sa, hr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Chromosome 8q24 is a susceptibility locus for multiple cancers, including prostate cancer. Here we combine genetic data across the 8q24 susceptibility region from 71,535 prostate cancer cases and 52,935 controls of European ancestry to define the overall contribution of germline variation at 8q24 to prostate cancer risk. We identify 12 independent risk signals for prostate cancer (p < 4.28 × 10−15), including three risk variants that have yet to be reported. From a polygenic risk score (PRS) model, derived to assess the cumulative effect of risk variants at 8q24, men in the top 1% of the PRS have a 4-fold (95%CI = 3.62–4.40) greater risk compared to the population average. These 12 variants account for ~25% of what can be currently explained of the familial risk of prostate cancer by known genetic risk factors. These findings highlight the overwhelming contribution of germline variation at 8q24 on prostate cancer risk which has implications for population risk stratification.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Date Crossref
05/11/2018
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

University of Southern CaliforniaInstitute of Cancer ResearchUniversity of CambridgeUniversity Hospitals Seidman Cancer CenterCase Western Reserve UniversityNational Cancer InstituteDivision of Cancer Epidemiology and GeneticsUniversity of ManchesterUniversity of WarwickAmerican Cancer SocietyFred Hutch Cancer CenterTranslational Research InstituteQueensland University of TechnologyKarolinska InstitutetMRC Epidemiology UnitUniversity College LondonUniversity of TurkuTampere UniversityTurku University HospitalTampere UniversityManchester Academic Health Science CentreThe Christie HospitalThe Christie NHS Foundation TrustHarvard UniversitySorbonne UniversitéHôpital TenonOnco-Urologie PrédictiveAarhus UniversityAarhus University HospitalOslo University HospitalThe University of Texas MD Anderson Cancer CenterCancer Research UKAddenbrooke's HospitalUniversity of OxfordUniversity of BristolPrincess Margaret Cancer CentreIcahn School of Medicine at Mount SinaiQueen Mary University of LondonThe University of MelbourneCancer Council VictoriaBrigham and Women's HospitalFundación Pública Galega de Medicina XenómicaServicio Gallego de SaludUniversity of South CarolinaUniversitat Pompeu FabraCenter for Research in Environmental EpidemiologyHospital Del MarMunicipal Institute for Medical ResearchBarcelona Institute for Global HealthCentro de Investigación Biomédica en Red de Epidemiología y Salud PúblicaMoffitt Cancer CenterUniversity of WashingtonInternational Hereditary Cancer CenterPomeranian Medical UniversityUniversity of CopenhagenGentofte HospitalGerman Cancer Research CenterHeidelberg UniversityNational Center for Tumor DiseasesUniversity Hospital UlmUniversidade do PortoInstituto Português de Oncologia Francisco GentilCity of HopeBeckman Research InstituteGhent UniversityUniversity of MalayaUniversität HamburgUniversity Medical Center Hamburg-EppendorfMedical University of SofiaUniversity of AlbertaKU LeuvenHealth Innovation ManchesterNIHR Manchester Biomedical Research CentreUniversity of California San DiegoComplejo Hospitalario Universitario de SantiagoInstituto de Investigación Sanitaria de SantiagoErasmus MCInsermCentre de recherche en Epidémiologie et Santé des PopulationsUniversity of UtahGeorge E. Wahlen Department of VA Medical CenterUniversity of SurreyMayo Clinic in ArizonaMayo ClinicRoyal Marsden NHS Foundation TrustQIMR Berghofer Medical Research InstituteThe University of QueenslandRoyal Brisbane and Women's HospitalThe Kinghorn Cancer CentreSouth Australian Health and Medical Research InstituteAustralian Regenerative Medicine InstituteMonash UniversityThe University of AdelaideTampere University HospitalFimlab (Finland)Finnish Cancer RegistryUniversity of HelsinkiHelsinki University HospitalUniversity of Maryland, BaltimoreLeidos (United States)University of SheffieldCambridge University Hospitals NHS Foundation TrustUniversity Health NetworkTokyo Medical CenterNational Hospital OrganizationNanfang HospitalSouthern Medical UniversityFirst Affiliated Hospital Zhejiang UniversitySecond Military Medical UniversityChanghai HospitalFirst Affiliated Hospital of Zhengzhou UniversityNorth Sichuan Medical UniversityShenyang Medical CollegeTissuPathComplexo Hospitalario Universitario A CoruñaHospital Universitari Germans Trias i PujolConsorci Institut D'Investigacions Biomediques August Pi I SunyerUniversitat de BarcelonaTUM KlinikumKing Abdulaziz UniversityUniversidade de Santiago de CompostelaClinique du MillénaireSBU - Swedish Agency for Health Technology Assessment and Assessment of Social ServicesUppsala UniversityUmeå UniversityÖrebro UniversityNational Institute for Health and Care ResearchNIHR Bristol Biomedical Research CentreMedical Research CouncilThe University of Texas at San Antonio Health Science CenterGriffith UniversityCancer Council QueenslandGarvan Institute of Medical ResearchChris O’Brien LifehousePeter MacCallum Cancer CentreKarolinska University HospitalWellcome Sanger InstituteWashington University in St. LouisUniversity of Rochester MedicineAlbert Einstein College of MedicineNanjing Medical UniversityThe Affiliated Yongchuan Hospital of Chongqing Medical UniversityChongqing Medical UniversityLiaoning Provincial People's HospitalChina Medical UniversityFudan UniversityZhongshan HospitalMonash HealthUniversity of TasmaniaJohn Radcliffe HospitalSDS Life Science (Sweden)Universidad de CantabriaInstituto de Investigación Marqués de ValdecillaLouisiana State University Health Sciences Center New OrleansNational Institutes of HealthNational Human Genome Research InstituteCopenhagen University HospitalRigshospitaletKrebsregister SaarlandCancer Prevention Institute of CaliforniaStanford Health CareStanford UniversityGhent University HospitalCancer Research MalaysiaSubang Jaya Medical CentreUniversity Hospital Centre ZagrebUniversity of ZagrebSouthampton General HospitalUniversity of SouthamptonUniversity Hospital Complex Of VigoEndeavor HealthImperial College LondonGenomics EnglandUniversity of Hawaiʻi at MānoaUniversity of Hawaii SystemCancer Center of HawaiiUniversity of Hawaii Cancer CenterDana-Farber Cancer InstituteUniversité Paris-Sud

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Genetic Associations and EpidemiologyGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesGenetic and phenotypic traits in livestock

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.